Casandra
Casandra Test Code NG80167Version 1 (DRAFT)
Performing Lab
MYC/IgH/CEN8 t(8;14)
Clinical Use
Order TestUse
The MYC/IgH rearrangement is common in Burkitt lymphoma and diffuse large B‑cell lymphoma, associated with a more aggressive tumor phenotype and a lower survival rate. MYC/IgH/CEN8 can confirm heavy chain rearrangement when MYC is rearranged.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
New York Approved
Methodology
Chromosomal / Cytogenetics (FISH)
Biomarkers
BLMH-DYNLT3 fusion
FusionRearrangement • Fusion • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Bone Marrow
Volume
1‑2 mL in sodium heparin tube
Minimum Volume
Not provided